IRB Number
|
# HY04-009
|
| Description |
This research study will evaluate
the safety and effectiveness of a research medication for diabetic people
who have mild swelling in the back of the eye (macular edema). Participants
will receive either the active research medication or placebo (inactive
substance). Possible benefits include; improvement of visual functioning and
slowing of the worsening of the macular degeneration |
| What is expected of me? |
Take one pill with the largest
meal everyday. Visit the clinic for a screening visit and then at least 7
more visits after that. |
| Inclusion Criteria |
18 yrs. or older, have type I or II diabetes, have diabetic macular edema
in the study eye |
| Exclusion Criteria |
Have a Hemoglobin A1C >11%, been in another research study within 30 days,
had laser treatment in the study eye. |
| Length of Study |
36 Months |
| Study Location |
Ophthalmology Clinical Trials
Center, UPC1, Suite 501 |
| Investigator Information |
Dr. David Quillen, Ophthalmology |
| To obtain more information about this study please contact: |
Susan Chobanoff
717-531-3790 |
